Aethlon Medical Inc

AEMD | Healthcare | NASDAQ
$0.79
0.00 (-0.58%)

Key Metrics

Market Cap
$87.46M
P/E Ratio
-0.12
EPS
$-6.67
Beta
N/A
Dividend Yield
N/A
ROE
-1.46%
Current Ratio
2.49

Company Information

Industry
Medical Devices

About Aethlon Medical Inc

Aethlon Medical Inc a medical technology company focuses on developing products to diagnose and treat life and organ threatening diseases in the United States The company develops Aethlon Hemopurifier a clinicalstage immunotherapeutic device that removes tumorderived exosomes and lifethreatening viruses from the human circulatory system including removal of COVID19 virus associated variants and related exosomes Aethlon Medical Inc has a collaboration with the University of Pittsburgh Medical Center Hillman Cancer Center for studies related to head and neck cancer The company was founded in 1999 and is based in San Diego California

Recent Earnings Surprises

Date Actual EPS Estimated EPS Surprise
2025-08-13 $-0.85 $-0.68 25.0%
2025-06-26 $-7.28 $-0.98 642.9%
2025-02-12 $-0.13 $-0.22 +-40.9%
2024-11-13 $-0.20 $-0.20 +0.0%

Financial Ratios (TTM)

Gross Margin
-797,729.00%
Operating Margin
-4,946.17%
Net Margin
-7,308.13%
ROA
-0.24%
Price to Book
0.00
Price to Sales
508.16